These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12641778

  • 1. CD44 and hyaluronate in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.
    Calikoglu E, Augsburger E, Chavaz P, Saurat JH, Kaya G.
    J Cutan Pathol; 2003 Mar; 30(3):185-9. PubMed ID: 12641778
    [Abstract] [Full Text] [Related]

  • 2. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
    Kahn HJ, Fekete E, From L.
    Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N, McNiff J, Hui P, Manfioletti G, Tallini G.
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [Abstract] [Full Text] [Related]

  • 4. Expression of nestin in dermatofibrosarcoma protuberans in comparison to dermatofibroma.
    Mori T, Misago N, Yamamoto O, Toda S, Narisawa Y.
    J Dermatol; 2008 Jul; 35(7):419-25. PubMed ID: 18705829
    [Abstract] [Full Text] [Related]

  • 5. Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
    Kim HJ, Lee JY, Kim SH, Seo YJ, Lee JH, Park JK, Kim MH, Cinn YW, Cho KH, Yoon TY.
    Br J Dermatol; 2007 Aug; 157(2):319-24. PubMed ID: 17596171
    [Abstract] [Full Text] [Related]

  • 6. Decreased CD44 expression and stromal hyaluronate accumulation in myxoid dermatofibroma.
    Calikoglu E, Chavaz P, Saurat JH, Kaya G.
    Dermatology; 2003 Aug; 207(1):104-6. PubMed ID: 12835568
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
    Labonte S, Hanna W, Bandarchi-Chamkhaleh B.
    J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of p53 expression in dermatofibrosarcoma protuberans and dermatofibroma: lack of correlation with proliferation rate.
    Díaz-Cascajo C, Bastida-Iñarrea J, Borrego L, Carretero-Hernández G.
    J Cutan Pathol; 1995 Aug; 22(4):304-9. PubMed ID: 7499569
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
    Chen YT, Chen WT, Huang WT, Wu CC, Chai CY.
    Kaohsiung J Med Sci; 2012 Oct; 28(10):545-9. PubMed ID: 23089320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.